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Objective: The aim of the present study was to characterize sickle cell disease retinopathy
in  children and teenagers from Bahia, the state in northeastern Brazil with the highest
incidence and prevalence of sickle cell disease.
Methods: A group of 51 sickle cell disease patients (36 hemoglobin SS and 15 hemoglobin
SC)  with ages ranging from 4 to 18 years was studied. Ophthalmological examinations were
performed in all patients. Moreover, a ﬂuorescein angiography was also performed in over
10-year-old patients.
Results: The most common ocular lesions were vascular tortuosity, which was found in nine
(25%) hemoglobin SS patients, and black sunburst, in three (20%) hemoglobin SC patients.
Peripheral arterial closure was observed in ﬁve (13.9%) hemoglobin SS patients and in three
(13.3%) hemoglobin SC patients. Arteriovenous anastomoses were present in six (16.5%)
hemoglobin SS patients and six (37.5%) hemoglobin SC patients. Neovascularization was
not  identiﬁed in any of the patients.
Conclusions: This study supports the use of early ophthalmological examinations in young
sickle cell disease patients to prevent the progression of retinopathy to severe disease and
further blindness.
©  2014 Associac¸ão Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published∗ Corresponding author at: Laboratório de Hematologia, Genética e Bio
(CPqGM), FIOCRUZ, Rua Waldemar Falcão, 121, Candeal, 40296-710 Salv
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patients, corresponding to 90% of the total number of cases.
Age-related ocular lesions, both non-proliferative and pro-
liferative (Goldberg) (Figs. 1–4), were very frequent in both
Figure 1 – Tortuous vessels in an 11-year-old female with
hemoglobin SS.rev bras hematol hemot
ntroduction
ickle cell disease (SCD) is characterized by the presence of
he hemoglobin S (Hb S) variant due to a single nucleotide
hange (GAG → GTG) in the ˇ-globin gene (HBB) that replaces a
lutamic acid with a valine at the sixth position of the -globin
hain. The hemoglobin C (Hb C) variant is characterized by a
oint mutation at the sixth position of the HBB gene, wherein
 lysine replaces a glutamic acid at the sixth position of the
-globin chain.1
Hb S has a high overall frequency worldwide; in Brazil
ts distribution is heterogeneous. In northeastern Brazil, in
articular in Bahia, the population has a tri-racial mixture
f Europeans (mostly Portuguese), Africans and indigenous
razilians.2 The frequency of Hb S in the state of Bahia is
he highest in Brazil, varying from 4.5 to 14.7% in different
opulation groups.3
Sickle cell disease is characterized by a variety of clinical
bnormalities that are frequently linked to hemolytic ane-
ia  and the vaso-occlusive processes often responsible for the
ain and other clinical features described by patients, includ-
ng retinopathy.1,4
ethods
he present study was approved by the Human Research
thics Board of the Fundac¸ão Oswaldo Cruz (FIOCRUZ), and
nformed consent was obtained from the guardians of partici-
ants in accordance with ethical principles and in accord with
he Helsinki Declaration of 1975 and its revisions. Ophthal-
ologic examinations were carried out and peripheral blood
amples were collected only after signed informed consent
as been obtained.
This cross-sectional study involved a group of 51 SCD
atients (36 Hb SS and 15 Hb SC) from the state of Bahia in
ortheastern Brazil and was carried out during the period of
anuary 2010 to December 2012.
Patients were randomly selected among those attending
he Hematology Outpatient Clinic at the Fundac¸ão de Hema-
ologia e Hemoterapia da Bahia (HEMOBA), a referral center for
CD patients who  are seen in routine visits. Patients were then
ent to the Instituto Brasileiro de Oftalmologia e Prevenc¸ão
a Cegueira (IBOPC) for an eye examination, including fun-
us biomicroscopy and indirect binocular ophthalmoscopy
n all patients and ﬂuorescein angiography in over 10-year-
ld patients. The following ﬁndings were observed in the
undoscopic examination: vascular tortuosity, black sunburst
attern, salmon patches and iridescent spots. The pathologic
lassiﬁcation of fundoscopic alterations as proliferative was
ased on Goldberg’s ﬁve stage grouping: stage I – peripheral
rteriolar occlusions; stage II – peripheral arteriovenous anas-
omoses; stage III – preretinal neovascularization; stage IV –
itreous hemorrhage and stage V – retinal detachment.
Patients with proliferative retinopathy were stratiﬁed by
ge and were classiﬁed as severe when displaying stages III–V.
he hemoglobin pattern was conﬁrmed in the Hematology,
enetic and Computacional Biology Laboratory of FIOCRUZ
nd the Universidade Federal da Bahia (UFBA) using high 1 4;3  6(5):340–344 341
performance liquid chromatography (HPLC – Variant I/BIO-
RAD, CA, USA).
SPSS version 18.0 and GraphPad version 5.0 were used to
store and analyze the data. Pearson’s Chi-squared or Fisher’s
exact tests were used to compare the two groups of SCD
patients as necessary. A p-value of less than 0.05 was con-
sidered statistically signiﬁcant.
Results
A total of 51 SCD patients were enrolled in this study: 36
(70.6%) with sickle cell anemia (SCA) or Hb SS and 15 (29.4%)
with Hb SC disease. Overall, the mean age of the patients
was 11.76 ± 3.69 years. The Hb SS group had a mean age of
11.39 ± 3.76 years, and the Hb SC group had a mean age of
13.29 ± 2.8 years. Overall 23 (45%) SCD patients were female
and 28 (55%) were male. In the Hb SS group, 19 patients
(52.78%) were male and 17 (47.22%) were female, and in the
Hb SC group, nine (60%) were male and six (40%) were female.
Visual acuity was 20/20 or 20/25 for the best eyes of allFigure 2 – Black sunburst. Hyperpigmented lesions
observed in the retinal periphery of an 18-year-old female
with hemoglobin SC.
342  rev bras hematol hemoter. 2 0 1 4;3  6(5):340–344
Figure 3 – Salmon patches in a 13-year-old male with
hemoglobin SC.
Figure 4 – Peripheral arteriolar occlusions and
arteriovenous anastomoses in a 14-year-old male with
sunbursts, were the most frequent changes, in accordancegroups of patients (Hb SS and Hb SC). Table 1 shows the dis-
tribution of ocular lesions across the two age groups. The Hb
SS group had more  ocular changes in the age range 0–9 years
old. In the Hb SC group of patients, ocular changes were more
frequent in the age range 10–18 years old.
Vascular tortuosity and black sunbursts were the most
common fundoscopic ocular lesions found in both SCD groups
(Hb SS and Hb SC). Table 2 shows that vascular tortuosity
lesions were most frequent in the Hb SS group. However, black
sunburst lesions were more  frequent in the Hb SC group. Iri-
descent spots were found in both groups of SCD patients.
Table 3 shows the distribution of proliferative ocular lesions
across Goldberg stages I–V in the Hb SS and Hb SC patient
groups. There were patients in both groups with proliferative
ocular lesions in Goldberg stages I and II; however, the Hb SS
group had more  proliferative ocular lesions in the ﬁrst stage
than the Hb SC group; this increased with age in the Hb SC
Table 1 – The distribution of retinal vessel occlusion lesions acr
Total (n = 51) Hemoglobin SC (n = 
n % n % 
Age (years)
0–9 4 36.4 – – 
10–18 7 17.5 9 22.2 
a Fisher’s exact test
Table 2 – Fundoscopic ocular non-proliferative lesions in both s
Hemoglobin SS (n = 36) Hemoglo
n % n 
Vascular tortuosity 9 25.0 1 
Black sunburst 2 5.6 3 
Salmon patches – – 1 
Angioid streaks – – – 
Disk sign – – – 
Iridescent spots 3 8.3 1 
Total 14 38.9 6 
a Chi-square.hemoglobin SC.
group. There were no cases of proliferative ocular lesions at
stages III–V in either of the groups of SCD patients.
Discussion
Several ocular changes were observed in the two  SCD patient
groups; however, no change in visual acuity was found, as has
previously been reported.5–10
Fundoscopic lesions, such as vascular tortuosity and blackwith previous Brazilian reports.7–11 The overall frequency of
vascular tortuosity was most frequently in SCA patients,
oss two age groups of sickle cell disease patients.
15) Hemoglobin SS (n = 36) p-valuea
n %
4 20.0 0.02
16 80.0 0.008
ickle cell disease groups.
bin SC (n = 15) Total (n = 51) p-valuea
% n %
6.7 10 19.6 0.95
20.0 5 9.8
6.7 1 2.0
– – –
– – –
6.7 4 7.8
40 20 39.3
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Table 3 – The distribution of proliferative ocular lesions for Goldberg stages I–V in the hemoglobin SS and hemoglobin SC
groups.
Hemoglobin SS Hemoglobin SC p-value Total
n % n % n %
Normal 25 69.4 6 40.0 0.09a 31 60.8
Ocular Lesions (Goldberg) 11 30.6 9 60.0 20 39.2
Stage I 5 13.9 3 13.3 08 15.7
Stage II 6 16.7 6 37.5 12 23.5
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1a Yates corrected Chi-square test.
s previously described.10–12 The black sunburst lesion was
bserved in both groups, although its frequency in Hb SC
atients was much lower than that described in previously
ublished studies.10–13 Salmon patch lesions were present
nly in the Hb SC group; however, their occurrence has been
eported in both groups albeit more  frequent in the Hb SC
roup.10–13 Iridescent spots were found in both groups, but
hey were less common than previously reported, which is
robably because these alterations are at sites of salmon patch
esolution and appear less in younger patients.14,15
This study indicates that retinal vascular disease occurs in
oth Hb SS and Hb SC patients and proliferative retinopathies
Goldberg stages) begin early in the Hb SS group and are more
ommon in both groups with older ages.11,12
Proliferative retinopathy (stages III–V) was not observed in
ur study, probably as the patients were very young rather
han old.16–20 Fox et al.19 studied Jamaican patients and
bserved that ocular proliferative lesions in both genotypes
ncrease with age.
onclusions
he ocular lesions described herein may help to deﬁne stan-
ardized protocols involving the clinical and ophthalmologic
ollow-up of Hb SS and Hb SC patients especially for younger
atients. Multiple ocular complications exist for SCD patients,
nd continuous assessment is required to detect lesions early
nough for effective prophylactic therapy.
It is necessary to recommend that SCD patients receive
eriodic ophthalmological examinations at early ages to pre-
ent progression of the disease and early blindness, establish
 more  effective treatment, and assure a better quality of care
or patients’ eyes.
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